Peer to Peer Mentoring For Individuals With Early Inflammatory Arthritis: An Effectiveness Study (Pilot RCT)- Peer Mentor Training

NCT01347372 | Completed

• 1 other identifier: 095-2011
• Study Type: interventional
• Target: 20
• Locations: 1 country
• Sites: 2

Brief Summary

Peer support (including informational, emotional, appraisal support) has been shown to help persons with chronic conditions. The goal of this research is to examine the impact of early peer support on the health and quality of life of individuals with early inflammatory arthritis (EIA). The investigators hypothesize that early peer support will result in improved use of disease modifying anti-rheumatic drug (DMARD) or biologic treatment, self-efficacy, coping efficacy, social support, health-related quality of life, self-management, and disease activity score as well as reduced anxiety for individuals with EIA within 2 years of their diagnosis. In this study, persons with IA will be trained as peer mentors using a training program developed for a pilot study. Individuals with EIA will be randomized to receive either "peer support program" or "standard care". Peer mentors will be paired with a person with EIA to provide one-on-one support (face-to-face or telephone) once a week for approximately 30 minutes over a 12-week period. All "standard care" participants will receive the peer mentoring intervention at the end of study. Both groups will be evaluated using self-administered questionnaires and clinical assessments, and results of the two groups will be compared. This information will be used to design a larger study.

Conditions

Early Inflammatory Arthritis

Keywords

peer support; peer mentoring; peer counselling; arthritis; chronic disease; inflammatory arthritis; early inflammatory arthritis; rheumatoid arthritis

Outcome Measures

Primary Outcomes (1)

• self-efficacy

  The primary goals of this study are to increase peer mentors' knowledge, confidence, skills and abilities to provide one-on-one support to individuals with EIA. It is anticipated that after training, peer mentors will be able to provide support to help persons with EIA to make informed decisions to self-manage their disease.

  0 months (baseline); immediate post-training; immediate post peer mentoring intervention and 3 months follow-up post peer mentoring intervention

Interventions

Peer Mentor Training BEHAVIORAL

Peer mentors will complete a training program (up to 20 hours) during which they will be evaluated. This face-to-face training applies an interactive format, with a combination of lectures, question/answer sessions, and experiential learning (e.g. role-playing, simulations) and practice sessions.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of IA from a physician;
• Disease duration at least 2 years and managing well;
• Currently using medications (DMARDS/biologics) to treat his/her arthritis
• Completion of Arthritis Self-Management Program (ASMP) provided by The Arthritis Society and/or similar program and/or have sufficient knowledge and experience with teaching or providing mentoring support to an individual living with a chronic disease;
• Able to attend a series of training sessions (approximately 20 hours in total);
• Able to take part in ongoing assessment/evaluation activities (self-report questionnaire; interviews, observation; study activity log)
• Able to commit to the duration of the research study (9 -12 months);
• Willing to provide ongoing one-on-one support to an individual newly diagnosed with IA;
• years of age or older; and
• Able to speak, understand, read and write English.

Sponsors & Collaborators

• Sunnybrook Health Sciences Centre: lead
• Canadian Rheumatology Association: collaborator
• The Arthritis Society, Canada: collaborator
• Mount Sinai Hospital, Canada: collaborator
• Unity Health Toronto: collaborator
• University of Toronto: collaborator

Study Sites (2)

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

Mount Sinai Hospital

Toronto, Ontario, M5T 3L9, Canada

Location

MeSH Terms

Conditions

Arthritis; Chronic Disease; Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Study Officials

• Mary J Bell, MD, FRCPC

  Sunnybrook Health Sciences Centre

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Rheumatologist

Study Record Dates

• First Submitted: May 2, 2011
• First Posted: May 4, 2011
• Study Start: May 1, 2011
• Primary Completion: May 1, 2013
• Study Completion: May 1, 2013
• Last Updated: April 12, 2018

Record last verified: 2018-04

Locations

CA (2)